Latest Research And Development News

Actinogen Medical has locked in up to $13.8 million in non-dilutive funding tied to its R&D tax incentives, bolstering its cash position as it advances a pivotal Alzheimer’s disease clinical trial.

Papyrus Australia reported a modest net operating cash outflow of $39,000 for May 2025, maintaining a solid cash position supported by available loan facilities that extend its funding runway to over 16 months.

MTM Critical Metals has raised A$50 million through a well-supported institutional placement to accelerate the rollout of its proprietary Flash Joule Heating technology in the U.S. This capital injection marks a pivotal step in MTM’s transformation into a U.S.-focused clean technology company.

Sparc Technologies has unveiled its first-of-its-kind photocatalytic water splitting pilot plant at the University of Adelaide, marking a key milestone in green hydrogen innovation. Commissioning is set to begin in July 2025, aiming to demonstrate a low-cost, modular alternative to traditional electrolysis.

Lithium Universe Limited has announced a $1.7 million capital raising via a two-tranche placement to fund the development of its Bécancour Lithium Refinery in Canada, alongside R&D initiatives and working capital needs.

HighCom Limited has recommissioned its XTclave™ system in Ohio, doubling production capacity and setting the stage for new ballistic product launches in FY26. The move strengthens its collaboration with the U.S. Department of Defense and positions the company for significant government contract opportunities.

Lithium Universe has acquired exclusive global rights to a pioneering microwave-based solar panel recycling technology from Macquarie University, aiming to revolutionize critical metal recovery and sustainability in the solar industry.

Lumos Diagnostics has enrolled 500 patients in its FebriDx CLIA waiver clinical study, unlocking a significant milestone payment from BARDA and moving closer to FDA approval that could open a US$1 billion market.

Recce Pharmaceuticals has locked in a non-dilutive A$30 million debt facility with Avenue Capital Group, extending its cash runway to support pivotal Phase 3 trials and commercialisation of its synthetic anti-infective R327G.

Charger Metals secures $500,000 from Rio Tinto and advances a $1.1 million exploration program at Lake Johnston, boosting its cash position and drilling activity in Western Australia’s lithium hotspot.

Cann Group Limited has received a $315,552 advance on its expected FY2025 Research and Development Tax Incentive, marking the second tranche of funding to support its ongoing cannabis medicine development.

Adisyn Ltd has successfully completed a key R&D program on low-temperature graphene deposition, earning full approval and final payment of a $520,000 grant from the Israel Innovation Authority. This milestone validates its cutting-edge semiconductor technology aimed at revolutionizing AI and high-performance computing.